Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study -

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
To evaluate whether atrial fibrillation (AF) therapies in Guidant Pulsar Max II or Insignia Plus DR have an effect on the occurance of AF in patients with no prior history of AF
Epistemonikos ID: 868579103a0eca7be5d0aafeeabf702e19203210
First added on: May 05, 2024